Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing Antibody Science

Advancing antibody drugs and biosimilars to address unmet medical needs.

Creating Value for a Healthier Life

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 78
Number Thumbnail Title Author Date Votes Views
28 Prestige Biopharma Secures Japanese Patent for Antibody Drug Candidate PBP1710 Targeting Solid Tumors
김** | 2025.01.21 | Votes 0 | Views 2246
김** 2025.01.21 0 2246
27 Prestige Biopharma Group Accelerates Drug Development with New R&D Hub Backed by KRW 200 Billion Investment
we******** | 2024.11.19 | Votes 0 | Views 2090
we******** 2024.11.19 0 2090
26 Prestige Biopharma IDC to Host First International Symposium on Emerging Biopharmaceutical Modalities
김** | 2024.11.15 | Votes 0 | Views 1186
김** 2024.11.15 0 1186
25 Prestige Biopharma IDC Opens New Innovative Discovery Center in Busan
김** | 2024.11.15 | Votes 0 | Views 1611
김** 2024.11.15 0 1611
24 Prestige Biopharma IDC CEO Sang-Seok Koh Receives Presidential Commendation
we******** | 2024.11.06 | Votes 0 | Views 1270
we******** 2024.11.06 0 1270
23 Prestige Biopharma IDC and Aptis Sign Collaboration for Next-Generation ADC Cancer Therapy Development
we******** | 2024.09.26 | Votes 0 | Views 1478
we******** 2024.09.26 0 1478
22 Prestige Biopharma Receives European Commission Approval for Herceptin Biosimilar Tuznue®
we******** | 2024.09.23 | Votes 0 | Views 2214
we******** 2024.09.23 0 2214
21 Prestige Biopharma Group Participates in BIO USA 2024 Exhibition
김** | 2024.06.16 | Votes 0 | Views 2495
김** 2024.06.16 0 2495
20 Prestige Biopharma IDC Appoints Dr. Koh Sang-seok, Discoverer of PAUF Protein, as CEO
김** | 2024.03.05 | Votes 0 | Views 1335
김** 2024.03.05 0 1335
19 Prestige Biopharma Explores Global Expansion of PAUF-Based Pancreatic Cancer Diagnostic Kit at MEDICA 2023
we******** | 2023.11.16 | Votes 0 | Views 1258
we******** 2023.11.16 0 1258

Read Prestige news >>

FY2026
Shareholder Letter
FY2026
Shareholder Letter